Front. Endocrinol. Frontiers in Endocrinology Front. Endocrinol. 1664-2392 Frontiers Media S.A. 10.3389/fendo.2023.1136544 Endocrinology Correction Corrigendum: Effect of 131 I with and without artificial liver support system in patients with Graves’ disease and severe liver dysfunction: A retrospective study Rao Maohua 1 † Wang Yirui 1 † Ren Jianli 2 Chen Yue 3 Zheng Chenxi 1 Xiong Yalan 1 Yan Qingbo 1 Li Shiying 4 * Yuan Gengbiao 1 * 1 Department of Nuclear Medicine, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China 2 Chongqing Key Laboratory of Ultrasound Molecular Imaging, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China 3 Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou, China 4 Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

*Correspondence: Shiying Li, 302946@hospital.cqmu.edu.cn; Gengbiao Yuan, 300784@hospital.cqmu.edu.cn

†These authors have contributed equally to this work and share first authorship

This article was submitted to Thyroid Endocrinology, a section of the journal Frontiers in Endocrinology

 22 02 2023 2023 14 1136544 03 01 2023 10 02 2023 Copyright © 2023 Rao, Wang, Ren, Chen, Zheng, Xiong, Yan, Li and Yuan 2023 Rao, Wang, Ren, Chen, Zheng, Xiong, Yan, Li and Yuan

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Corrigendum on Effect of 131I with and without artificial liver support system in patients with Graves’ disease and severe liver dysfunction: A retrospective study By Rao M, Wang Y, Ren J, Chen Y, Zheng C, Xiong Y, Yan Q, Li S and Yuan G (2022) Front. Endocrinol. 13:1034374. doi: 10.3389/fendo.2022.1034374 thyroid severe liver dysfunction artificial liver support system radioiodine therapeutics

In the published article, there was an error in the author list. The symbol indicating which authors shared co-first authorship was erroneously missed. The corrected author list appears below, using the symbol † to define which authors share first authorship.

Maohua Rao1†, Yirui Wang1†, Jianli Ren2, Yue Chen3, Chenxi Zheng1, Yalan Xiong1, Qingbo Yan1, Shiying Li4*and Gengbiao Yuan1*

The authors apologize for this error and state that this does not change the scientific conclusions of the article in anyway. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.